IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $146,445,987 | +205.9% | 3,814,691 | +51.1% | 4.88% | +252.5% |
| Q2 2023 | $47,876,164 | +138.9% | 2,523,783 | +95.4% | 1.39% | +134.1% |
| Q1 2023 | $20,036,718 | +652.6% | 1,291,858 | +761.2% | 0.59% | +689.3% |
| Q4 2022 | $2,662,500 | -95.9% | 150,000 | -89.3% | 0.08% | -89.2% |
| Q4 2020 | $64,666,000 | +31.3% | 1,400,000 | 0.0% | 0.69% | -3.5% |
| Q3 2020 | $49,266,000 | +83.9% | 1,400,000 | +27.3% | 0.72% | +65.7% |
| Q2 2020 | $26,785,000 | – | 1,100,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |